-
公开(公告)号:US08450307B2
公开(公告)日:2013-05-28
申请号:US11628569
申请日:2005-06-06
申请人: Bruce J. Sargent , Henry Pauls , Judd M. Berman , Jailall Ramnauth , Peter Sampson , Andras Toro , Fernando J. Martin , Matthew D. Surman , Helene Y. Decornez , David D. Manning
发明人: Bruce J. Sargent , Henry Pauls , Judd M. Berman , Jailall Ramnauth , Peter Sampson , Andras Toro , Fernando J. Martin , Matthew D. Surman , Helene Y. Decornez , David D. Manning
IPC分类号: C07D401/12 , C07D405/12 , C07D409/12 , C07D498/04 , A61K31/551 , A61K31/5365
CPC分类号: C07D498/04 , C07D401/12 , C07D405/12 , C07D409/12 , C07D471/04 , C07D471/14
摘要: In part, the present invention is directed to antibacterial compounds.
摘要翻译: 部分地,本发明涉及抗菌化合物。
-
公开(公告)号:US20100093705A1
公开(公告)日:2010-04-15
申请号:US11628569
申请日:2005-06-06
申请人: Bruce J. Sargent , Henry Pauls , Judd M. Berman , Jailall Ramnauth , Peter Sampson , Andras Toro , Fernando J. Martin , Matthew D. Surman , Helene Y. Decornez , David D. Manning
发明人: Bruce J. Sargent , Henry Pauls , Judd M. Berman , Jailall Ramnauth , Peter Sampson , Andras Toro , Fernando J. Martin , Matthew D. Surman , Helene Y. Decornez , David D. Manning
IPC分类号: A61K31/551 , C07D471/04 , C07D223/16 , C07D491/02 , A61K31/4375 , A61P31/04
CPC分类号: C07D498/04 , C07D401/12 , C07D405/12 , C07D409/12 , C07D471/04 , C07D471/14
摘要: In part, the present invention is directed to antibacterial compounds.
摘要翻译: 部分地,本发明涉及抗菌化合物。
-
公开(公告)号:US09040714B2
公开(公告)日:2015-05-26
申请号:US13639734
申请日:2011-04-05
申请人: Qingping Zeng , Andras Toro , John Bruce Patterson , Warren Stanfield Wade , Zoltan Zubovics , Yun Yang , Zhipeng Wu
发明人: Qingping Zeng , Andras Toro , John Bruce Patterson , Warren Stanfield Wade , Zoltan Zubovics , Yun Yang , Zhipeng Wu
IPC分类号: C07D311/16 , C07D405/10 , C07D417/04 , A61K31/366 , A61K31/343 , A61K31/352 , A61K31/37 , A61K31/381 , A61K31/4025 , A61K31/404 , A61K31/4045 , A61K31/415 , A61K31/4155 , A61K31/4172 , A61K31/4184 , A61K31/423 , A61K31/427 , A61K31/4433 , A61K31/4439 , A61K31/452 , A61K31/453 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/5377 , A61K45/06 , C07D311/20 , C07D311/94 , C07D401/04 , C07D405/04 , C07D409/04
CPC分类号: A61K31/366 , A61K31/343 , A61K31/352 , A61K31/37 , A61K31/381 , A61K31/4025 , A61K31/404 , A61K31/4045 , A61K31/415 , A61K31/4155 , A61K31/4172 , A61K31/4184 , A61K31/423 , A61K31/427 , A61K31/4433 , A61K31/4439 , A61K31/452 , A61K31/453 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/5377 , A61K45/06 , C07D217/02 , C07D217/08 , C07D311/12 , C07D311/16 , C07D311/20 , C07D311/22 , C07D311/94 , C07D401/04 , C07D401/12 , C07D405/04 , C07D405/10 , C07D409/04 , C07D417/04 , Y02A50/389 , Y02A50/393
摘要: Compounds which directly inhibit IRE-1α activity in vitro, prodrugs, and pharmaceutically acceptable salts there-of. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response or with regulated IRE1-dependent decay (RIDD) and can be used as single agents or in combination therapies.
摘要翻译: 在体外直接抑制IRE-1α活性的化合物,其前体药物和药学上可接受的盐。 这些化合物和前药可用于治疗与未折叠的蛋白质应答相关的疾病或者与调节的IRE1依赖性衰变(RIDD)相关的疾病,并可用作单一药物或联合疗法。
-
公开(公告)号:US07425631B2
公开(公告)日:2008-09-16
申请号:US10823377
申请日:2004-04-12
申请人: Robert D. Groneberg , Benny C. Askew, Jr. , Derin C. D'Amico , James Zhan , Andras Toro , Youngboo Kim , David A. Mareska , Nianhe Han , Christopher H. Fotsch , Qingyian Liu , Babak Riahi , Kevin Yang , Aiwen Li , Chester Chenguang Yuan , Kaustav Biswas , Scott Harried , Thomas Nguyen , Wenyuan Qian , Jian Jeffrey Chen , Rana Nomak
发明人: Robert D. Groneberg , Benny C. Askew, Jr. , Derin C. D'Amico , James Zhan , Andras Toro , Youngboo Kim , David A. Mareska , Nianhe Han , Christopher H. Fotsch , Qingyian Liu , Babak Riahi , Kevin Yang , Aiwen Li , Chester Chenguang Yuan , Kaustav Biswas , Scott Harried , Thomas Nguyen , Wenyuan Qian , Jian Jeffrey Chen , Rana Nomak
IPC分类号: C07D215/04
CPC分类号: C07C311/19 , C07C311/13 , C07C311/29 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07C2602/10 , C07D205/04 , C07D207/12 , C07D207/16 , C07D207/20 , C07D209/14 , C07D209/16 , C07D209/40 , C07D209/52 , C07D211/38 , C07D211/44 , C07D211/46 , C07D211/60 , C07D211/70 , C07D213/42 , C07D213/56 , C07D213/64 , C07D215/38 , C07D215/40 , C07D215/42 , C07D217/22 , C07D233/54 , C07D239/74 , C07D271/08 , C07D277/64 , C07D279/02 , C07D285/14 , C07D295/125 , C07D295/13 , C07D295/135 , C07D307/14 , C07D307/28 , C07D307/79 , C07D307/81 , C07D311/68 , C07D317/58 , C07D333/20 , C07D333/24 , C07D333/58 , C07D333/62 , C07D405/04 , C07D405/06 , C07D405/12 , C07D407/06 , C07D407/12 , C07D409/06 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/08
摘要: Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
摘要翻译: 所选化合物对于治疗疼痛和疾病如炎症介导的疾病是有效的。 本发明包括新的化合物,类似物,前药和其药学上可接受的衍生物,用于预防和治疗疾病和其它疾病或涉及疼痛,炎症等的病症的药物组合物和方法。 本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。
-
公开(公告)号:US20050124654A1
公开(公告)日:2005-06-09
申请号:US10823377
申请日:2004-04-12
申请人: Robert Groneberg , Bonny Askew , Derin D'Amico , James Zhan , Andras Toro , Youngboo Kim , David Mareska , Nianhe Han , Christopher Fotsch , Qingyian Liu , Babak Riahi , Kevin Yang , Aiwen Li , Chester Yuan , Kaustav Biswas , Scott Harried , Thomas Nguyen , Wenyuan Qian , Jian Chen , Rana Nomak
发明人: Robert Groneberg , Bonny Askew , Derin D'Amico , James Zhan , Andras Toro , Youngboo Kim , David Mareska , Nianhe Han , Christopher Fotsch , Qingyian Liu , Babak Riahi , Kevin Yang , Aiwen Li , Chester Yuan , Kaustav Biswas , Scott Harried , Thomas Nguyen , Wenyuan Qian , Jian Chen , Rana Nomak
IPC分类号: A61K31/18 , A61K31/277 , A61K31/405 , A61K31/47 , A61P25/04 , A61P29/00 , C07C311/19 , C07C311/29 , C07D205/04 , C07D207/12 , C07D207/16 , C07D207/20 , C07D209/14 , C07D209/16 , C07D209/40 , C07D209/52 , C07D211/38 , C07D211/44 , C07D211/46 , C07D211/60 , C07D211/70 , C07D213/42 , C07D213/56 , C07D213/64 , C07D215/38 , C07D215/40 , C07D215/42 , C07D217/22 , C07D233/54 , C07D239/74 , C07D271/08 , C07D277/64 , C07D279/02 , C07D285/14 , C07D295/125 , C07D295/13 , C07D295/135 , C07D307/14 , C07D307/28 , C07D307/79 , C07D307/81 , C07D311/68 , C07D317/58 , C07D333/20 , C07D333/24 , C07D333/58 , C07D333/62 , C07D405/04 , C07D405/06 , C07D405/12 , C07D407/06 , C07D407/12 , C07D409/06 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/08
CPC分类号: C07C311/19 , C07C311/13 , C07C311/29 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07C2602/10 , C07D205/04 , C07D207/12 , C07D207/16 , C07D207/20 , C07D209/14 , C07D209/16 , C07D209/40 , C07D209/52 , C07D211/38 , C07D211/44 , C07D211/46 , C07D211/60 , C07D211/70 , C07D213/42 , C07D213/56 , C07D213/64 , C07D215/38 , C07D215/40 , C07D215/42 , C07D217/22 , C07D233/54 , C07D239/74 , C07D271/08 , C07D277/64 , C07D279/02 , C07D285/14 , C07D295/125 , C07D295/13 , C07D295/135 , C07D307/14 , C07D307/28 , C07D307/79 , C07D307/81 , C07D311/68 , C07D317/58 , C07D333/20 , C07D333/24 , C07D333/58 , C07D333/62 , C07D405/04 , C07D405/06 , C07D405/12 , C07D407/06 , C07D407/12 , C07D409/06 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/08
摘要: Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
摘要翻译: 所选化合物对于治疗疼痛和疾病如炎症介导的疾病是有效的。 本发明包括新的化合物,类似物,前药和其药学上可接受的衍生物,用于预防和治疗疾病和其它疾病或涉及疼痛,炎症等的病症的药物组合物和方法。 本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。
-
公开(公告)号:US20090048224A1
公开(公告)日:2009-02-19
申请号:US12205616
申请日:2008-09-05
申请人: Robert D. Groneberg , Benny C. Askew, JR. , Derin C. D'Amico , James Zhan , Andras Toro , Youngboo Kim , David A. Mareska , Nianhe Han , Christopher H. Fotsch , Qingyian Liu , Babak Riahi , Kevin Yang , Aiwen Li , Chester Chenguang Yuan , Kaustav Biswas , Scott Harried , Thomas Nguyen , Wenyuan Qian , Jian Jeffrey Chen , Rana Nomak
发明人: Robert D. Groneberg , Benny C. Askew, JR. , Derin C. D'Amico , James Zhan , Andras Toro , Youngboo Kim , David A. Mareska , Nianhe Han , Christopher H. Fotsch , Qingyian Liu , Babak Riahi , Kevin Yang , Aiwen Li , Chester Chenguang Yuan , Kaustav Biswas , Scott Harried , Thomas Nguyen , Wenyuan Qian , Jian Jeffrey Chen , Rana Nomak
IPC分类号: A61K31/397 , A61K31/453 , C07D401/02 , C07D405/02 , A61K31/496 , A61K31/4545 , C07D407/02 , A61K31/4025 , A61K31/351 , A61P27/02 , A61P27/06 , A61P11/06 , A61P9/00 , A61P19/02 , A61P25/28 , A61K31/4375 , C07D471/04 , C07D205/04 , A61P3/10 , C07D311/02 , C07D413/02 , A61K31/5377 , A61K31/5415 , C07D279/02 , C07C311/01 , A61K31/18
CPC分类号: C07C311/19 , C07C311/13 , C07C311/29 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07C2602/10 , C07D205/04 , C07D207/12 , C07D207/16 , C07D207/20 , C07D209/14 , C07D209/16 , C07D209/40 , C07D209/52 , C07D211/38 , C07D211/44 , C07D211/46 , C07D211/60 , C07D211/70 , C07D213/42 , C07D213/56 , C07D213/64 , C07D215/38 , C07D215/40 , C07D215/42 , C07D217/22 , C07D233/54 , C07D239/74 , C07D271/08 , C07D277/64 , C07D279/02 , C07D285/14 , C07D295/125 , C07D295/13 , C07D295/135 , C07D307/14 , C07D307/28 , C07D307/79 , C07D307/81 , C07D311/68 , C07D317/58 , C07D333/20 , C07D333/24 , C07D333/58 , C07D333/62 , C07D405/04 , C07D405/06 , C07D405/12 , C07D407/06 , C07D407/12 , C07D409/06 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/08
摘要: Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
摘要翻译: 所选化合物对于治疗疼痛和疾病如炎症介导的疾病是有效的。 本发明包括新的化合物,类似物,前药和其药学上可接受的衍生物,用于预防和治疗疾病和其它疾病或涉及疼痛,炎症等的病症的药物组合物和方法。 本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。
-
7.Process for the preparation of steroids bearing 17.alpha.-hydroxy-20-oxopregnane side chain 失效
标题翻译: 制备支链17(ALPHA) - 羟基-20-氧化二苯胺侧链的方法公开(公告)号:US5241063A
公开(公告)日:1993-08-31
申请号:US717823
申请日:1991-06-19
申请人: Andras Toro , Gabor Ambrus , Istvan Pallagi , Nandor Makk , Gyula Horvath , Ferenc Szederkenyi , Eva Ilkoy , Antonia Jekkel , Imre Moravcsik , Kalman Konczol
发明人: Andras Toro , Gabor Ambrus , Istvan Pallagi , Nandor Makk , Gyula Horvath , Ferenc Szederkenyi , Eva Ilkoy , Antonia Jekkel , Imre Moravcsik , Kalman Konczol
CPC分类号: C07J7/0045 , C07J21/00
摘要: The invention relates to a novel process for the preparation of 17 .alpha.-hydroxy-20-oxopregnane derivatives of the general formula (I), ##STR1## wherein R.sub.1 means a hydroxy or an oxo group; andthe dotted lines optionally represent one or more additional valence bond(s), with the proviso that the dotted line in the 4-position and the dotted line in the 5-position cannot each simultaneously be an additional valence bond from steroids having 23,24-dinor-17(20)-dehydrocholan-22-oic -22-oic acid structure.According to the process of the invention a steroid derivative having 23,24-dinorcholan-22-oic acid structure, containing a double bond in 17(20)-position, is transformed to 17.alpha., 20-epoxy-23,24-dinorcholanoic acid, the latter is converted to a reactive acid derivative, which is then reacted with a salt-containing azide ion to yield a 17.alpha., 20-epoxy-23,24-dinorcholanoic acyl azide derivative and the azide obtained is reacted with a mineral or organic acid in an aqueous medium.
摘要翻译: 本发明涉及制备通式(I)的17α-羟基-20-氧代孕烷衍生物的新方法,其中R1表示羟基或氧代基; 并且虚线可选地表示一个或多个另外的价键,条件是4-位中的虚线和5-位的虚线不能同时作为具有23的类固醇的另外的价键, 24-二酮-17(20) - 脱氢胆烷-22-酸-22-酸结构。 根据本发明的方法,在17(20) - 位中含有双键的具有23,24-二肌醇二十二酸结构的类固醇衍生物转化为17α,20-环氧-23,24-二肉桂酸 酸,后者转化为反应性酸衍生物,然后与含盐的叠氮化物离子反应,得到17α,20-环氧-23,24-二牛油酰基叠氮化物衍生物,所得叠氮化物与矿物质反应 或有机酸。
-
公开(公告)号:US20130116247A1
公开(公告)日:2013-05-09
申请号:US13639734
申请日:2011-04-05
申请人: Qingping Zeng , Andras Toro , John Bruce Patterson , Warren Stanfield Wade , Zoltan Zubovics , Yun Yang , Zhipeng Wu
发明人: Qingping Zeng , Andras Toro , John Bruce Patterson , Warren Stanfield Wade , Zoltan Zubovics , Yun Yang , Zhipeng Wu
IPC分类号: A61K31/366 , A61K31/496 , A61K31/5377 , C07D405/04 , A61K31/4025 , C07D405/10 , A61K31/453 , C07D417/04 , A61K31/427 , A61K31/4155 , C07D401/04 , A61K31/4433 , C07D409/04 , C07D311/94 , A61K45/06 , C07D311/20
CPC分类号: A61K31/366 , A61K31/343 , A61K31/352 , A61K31/37 , A61K31/381 , A61K31/4025 , A61K31/404 , A61K31/4045 , A61K31/415 , A61K31/4155 , A61K31/4172 , A61K31/4184 , A61K31/423 , A61K31/427 , A61K31/4433 , A61K31/4439 , A61K31/452 , A61K31/453 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/5377 , A61K45/06 , C07D217/02 , C07D217/08 , C07D311/12 , C07D311/16 , C07D311/20 , C07D311/22 , C07D311/94 , C07D401/04 , C07D401/12 , C07D405/04 , C07D405/10 , C07D409/04 , C07D417/04 , Y02A50/389 , Y02A50/393
摘要: Compounds which directly inhibit IRE-1α activity in vitro, prodrugs, and pharmaceutically acceptable salts there-of. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response or with regulated IRE1-dependent decay (RIDD) and can be used as single agents or in combination therapies.
摘要翻译: 直接抑制体外IRE-1α活性的化合物,其前体药物和药学上可接受的盐。 这些化合物和前药可用于治疗与未折叠的蛋白质应答相关的疾病或者与调节的IRE1依赖性衰变(RIDD)相关的疾病,并可用作单一药物或联合疗法。
-
公开(公告)号:US08318720B2
公开(公告)日:2012-11-27
申请号:US12374444
申请日:2007-07-19
申请人: Heinz W. Pauls , Jailall Ramnauth , Peter Sampson , Andras Toro
发明人: Heinz W. Pauls , Jailall Ramnauth , Peter Sampson , Andras Toro
IPC分类号: C07D471/04 , C07D405/12 , C07D409/12 , C07D213/73 , C07D401/12 , C07D495/04 , A61K31/4427 , A61K31/5513 , A61K31/4422 , A61K31/5375 , A61K31/381
CPC分类号: C07D471/04 , A01N43/90 , C07D498/04
摘要: In part, the present invention is directed to antibacterial compounds.
摘要翻译: 部分地,本发明涉及抗菌化合物。
-
公开(公告)号:US20100130470A1
公开(公告)日:2010-05-27
申请号:US12374444
申请日:2007-07-19
申请人: Heinz W. Pauls , Jailall Ramnauth , Peter Sampson , Andras Toro
发明人: Heinz W. Pauls , Jailall Ramnauth , Peter Sampson , Andras Toro
IPC分类号: A61K31/553 , C07D498/04 , A61K31/551 , A61P31/04
CPC分类号: C07D471/04 , A01N43/90 , C07D498/04
摘要: In part, the present invention is directed to antibacterial compounds.
摘要翻译: 部分地,本发明涉及抗菌化合物。
-
-
-
-
-
-
-
-
-